Niranjan Sardesai is the founder of Geneos Therapeutics. Geneos Therapeutics has raised $40M in total funding. Latest round: Series A.
Dr. Niranjan Sardesai is the Founder, President, and CEO of Geneos Therapeutics, a clinical-stage biotherapeutics company developing DNA-based personalized cancer vaccines for hepatocellular carcinoma. He founded Geneos after serving as Chief Operating Officer at Inovio Pharmaceuticals, where he helped build the company into a Phase III cancer and infectious disease immunotherapy firm.
Full founder directory · Investor directory · Company funding database · Fundraising library